AURA 2023 includes data and analyses from 2020–2022 (primarily 2020–2021) from various sources and reports on patterns and trends in antimicrobial use and appropriateness and antimicrobial resistance (AMR) in Australian acute and community healthcare settings.

This complete version of the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard describes what each quality statement means for patients and their families, clinicians, and health service organisations, and provides indicators for local monitoring. It includes information about using clinical care standards, and the background and evidence sources for this standard.

These Guidelines replace the 2017 publication titled the National Guidelines for On-Screen Presentation of Discharge Summaries. 

This communiqué summarises the final meeting of the National Sepsis Program Extension. It may be used by members to update their nominating organisations and other key agencies about the National Sepsis Program Extension (Program Extension).

This communiqué provides an update on the ninth meeting of the National Sepsis Program Oversight Group (Oversight Group). It may be used by members to update their nominating organisations and other key agencies about the National Sepsis Program Extension (Program Extension). 

Diabetes is one of Australia’s most pressing and complex health challenges, affecting more than 1.5 million people and contributing to long-term complications, hospitalisations and premature deaths. The National Medicines Symposium 2025, hosted by the Australian Commission on Safety and Quality in Health Care, will explore this issue under the theme ‘Quality use of medicines in people with diabetes’.

This issue includes items on Infection Prevention and Control Week, antimicrobial resistance, mental health, patient safety investigation, innovation, financial impacts, and more. Along with the latest from Australian Prescriber, Healthcare Quarterly,  BMJ Quality & Safety and Health Policy.